Physician profile
Alan M Blaker
NPI 1255399069
$30,102.67
in general payments reported to CMS, 2019-2025
52 companies · $1,805 in 2025
The $1,805 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $4,681 · 2021: $1,453 · 2022: $1,655 · 2023: $1,535 · 2024: $2,659 · 2025: $1,805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,998.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15,399.79 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $4,786.20 | 2019-2024 | Xarelto |
| Abbott Laboratories | $956.77 | 2019-2025 | Pressurewire, Xience Skypoint, Diamondback Coronary |
| Astrazeneca Pharmaceuticals LP | $891.66 | 2019-2025 | Farxiga, Wainua, Andexxa |
| Boston Scientific Corporation | $694.30 | 2019-2025 | Watchman Access System, Watchman Flx, Avvigo Guidance System |
| E.R. Squibb & Sons, L.L.C. | $670.39 | 2019-2025 | Camzyos, Eliquis, Empliciti |
| Pfizer INC. | $589.41 | 2019-2025 | |
| Amgen INC. | $567.42 | 2019-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $520.51 | 2020-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $508.75 | 2019-2025 | Lifevest |
| Vital Connect, INC | $425.83 | 2022-2024 | Vitalpatch Rtm |
| Merck Sharp & Dohme LLC | $393.39 | 2021-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $367.03 | 2021-2025 | Jardiance |
| Shockwave Medical, INC | $362.04 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Inari Medical, INC. | $353.27 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $263.14 | 2023-2025 | Barostim Neo System |
| Chiesi USA, INC. | $260.61 | 2019-2025 | Kengreal, Cleviprex |
| Medtronic, INC. | $218.82 | 2021-2024 | Symplicity G3 |
| Biotronik INC. | $185.88 | 2019-2020 | |
| Medtronic Vascular, INC. | $164.10 | 2019-2020 | |
| Novo Nordisk INC | $141.57 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Philips North America LLC | $129.25 | 2020-2024 | (Br0) Coronary Atherectomy |
| Sanofi-Aventis U.S. LLC | $116.82 | 2019-2023 | |
| Edwards Lifesciences Corporation | $97.02 | 2019 | |
| Astellas Pharma US INC | $93.78 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $88.54 | 2025 | Optimizer |
| Asahi Intecc USA, INC. | $87.82 | 2022 | |
| Atricure, INC. | $65.11 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Lexicon Pharmaceuticals, INC. | $55.19 | 2023 | Inpefa |
| Cardinal Health 200 LLC | $53.55 | 2019-2021 | |
| Amarin Pharma, INC. | $46.90 | 2019-2021 | |
| Ge Healthcare | $42.82 | 2020-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $40.91 | 2024 | Arcalyst |
| Biosense Webster, INC. | $38.51 | 2022 | |
| Alnylam Pharmaceuticals INC. | $36.49 | 2021-2025 | Amvuttra |
| Intuitive Surgical, INC. | $33.46 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $30.35 | 2025 | Opsynvi, Uptravi |
| Abiomed | $28.79 | 2024 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $26.25 | 2025 | |
| Heartflow, INC. | $26.15 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $25.92 | 2019 | |
| Inspire Medical Systems, INC. | $25.31 | 2024 | Inspire |
| Hitachi Healthcare Americas Corp. | $25.11 | 2020 | |
| Corcept Therapeutics | $24.67 | 2025 | Korlym |
| Daiichi Sankyo INC. | $23.54 | 2024 | Injectafer |
| Scpharmaceuticals INC. | $21.88 | 2025 | |
| Stryker Corporation | $21.40 | 2025 | Flowtriever |
| Terumo Medical Corporation | $16.30 | 2020 | |
| Portola Pharmaceuticals, LLC | $16.14 | 2019 | |
| Lilly USA, LLC | $16.10 | 2025 | Mounjaro, Zepbound |
| Gilead Sciences, INC. | $14.26 | 2019 | |
| Preventice Services, LLC | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Blaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.